Discover neotiv, a science-driven spinoff in the field of Alzheimer’s. 🧠🔬
neotiv provides mobile cognitive tests that are embedded in a digital platform for smartphone and tablets. In doing so, its goal is to offer a widespread digital #biomarker for early detection and intervention in cognitive issues like dementia and Alzheimer’s.
On their path, our #venture-builder #ROX played a pivotal role, offering:
🔍 crucial regulatory support
💼 guidance through market access challenges
🤝 a game-changing introduction to Roche for a commercial collaboration while actively contributing to shape and negotiate the partnership and contract
Curious to learn more about this inspiring journey?
Tune in to our interview with Dr. Olivier Flückiger, Co-founder and Medical & Market Access Expert at ROX, Dr. Chris Rehse, Founder and CEO of neotiv, and Dr. Michael Schoettler, Head of Neurodegenerative & Rare Diseases at Roche Pharma AG.
Watch our video now for insights on forging successful partnerships and accelerating innovation in digital health. Let’s fight Alzheimer’s together!